Skip to main content
Clinical Trials/NCT01934322
NCT01934322CompletedNot Applicable

Case Management for Frequent Users of the Emergency Department: A Randomized Controlled Trial

University of Lausanne1 site in 1 country250 target enrollmentStarted: June 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
250
Locations
1
Primary Endpoint
number of Emergency Department visits

Study Overview

Brief Summary

The purpose of this study is to evaluate a specific case management intervention for frequent users (FU) of Emergency Department (ED).

Compared to infrequent or non-users, most of the ED-FU visitors are identified as vulnerable patients because they are more likely to be of low social and economical status, be more isolated and live alone. They report more chronic medical conditions, have a higher mortality rate and consume more healthcare resources.

In the literature, interventions aimed at improving the management of ED-FU have demonstrated several positive outcomes, but there are still some knowledge gaps.

The proposed project tests the hypotheses that case management intervention as compared with standard emergency care

  • is a more efficient use of healthcare resources and reduces ED attendance,
  • is cost-saving and
  • improves quality of life,
  • altogether leading to favorable cost-utility ratio.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •5 or more attendances during the previous 12 months at the Emergency Department of the University Hospital of Lausanne
  • •Be capable of communicating in any of the languages spoken by the team (i.e. French, English, German, Italian and Spanish) or through a community interpreter

Exclusion Criteria

  • •Patients who cannot give informed consent or are ineligible to receive Case Managers services (e.g. acutely confused, acutely psychotic, intoxicated)
  • •Patients who are in prison
  • •Patients with a diagnose of cognitive disorders (delirium, dementia, and other cognitive disorders)
  • •Patients who are not expected to survive at least 18 months after enrollment
  • •Patients who will not remain in Switzerland for 12 to 18 months after enrollment
  • •Family members of a participant already included

Arms & Interventions

Case Management

Experimental

Furnish specific assistance and to provide referrals for the patients:

  • If the social determinants are not adequate, the team will lend assistance for obtaining income entitlements, health insurance coverage if eligible, stable housing, schooling for children, etc.
  • If there are mental disturbances, the team will refer to mental health departments inside the hospital, and if necessary, to a psychiatrist, psychologist or general practitioner (GP) out in the community.
  • If the patient presents risk behaviors, the team will refer to substance abuse services and links to community services in order to maintain continuity of care.
  • In case of somatic problems, the team will find a new GP or make contact with the previous provider, contingent on the patient's consent.

Intervention: Case Management (Other)

Control

No Intervention

Patients randomized to control group (usual care) will receive standard emergency care by physicians (resident or attending physician) and nurses, without the case manager been involved. Nevertheless, the mobile team will take contact with each patient of the control group, giving them short information through a flyer (flyer) which will underline the existence of the mobile team, its addresses and telephone numbers.

Outcomes

Primary Outcomes

number of Emergency Department visits

Time Frame: 12 months after enrollement

Secondary Outcomes

  • total costs of the healthcare resource(12 months after enrollement)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr Patrick Bodenmann

PD, MER, MSc

University of Lausanne

Study Sites (1)

Loading locations...

Similar Trials